(Q33907780)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Interventions for psoriatic arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

G Jones

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Brooks

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 January 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

CD000212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

Sulphasalazine in psoriatic arthritis: a double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

Therapeutic value of colchicine in the treatment of patients with psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

Fumaric Acid Therapy for Psoriatic Arthritis. A Randomized, Double-blind, Placebo-controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

Treatment of psoriasis and psoriatic arthritis with interferon gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

Chrysotherapy in psoriatic arthritis. Efficacy and toxicity compared to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

Psoriatic arthritis. Follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000212

10.1002/14651858.CD000212

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10796328%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

1 reference